|
METAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99980000004096E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.90989956761723E-10 |
| Normal-vs-Stage2 |
1.623410E-01 |
| Normal-vs-Stage3 |
1.296850E-01 |
| Normal-vs-Stage4 |
2.244400E-01 |
| Stage1-vs-Stage2 |
7.394500E-02 |
| Stage1-vs-Stage3 |
3.550100E-02 |
| Stage1-vs-Stage4 |
6.09719999999925E-05 |
| Stage2-vs-Stage3 |
9.585600E-01 |
| Stage2-vs-Stage4 |
5.786200E-02 |
| Stage3-vs-Stage4 |
5.340400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89429999464252E-08 |
| Normal-vs-AfricanAmerican |
1.779990E-03 |
| Normal-vs-Asian |
6.400400E-01 |
| Caucasian-vs-AfricanAmerican |
3.092800E-01 |
| Caucasian-vs-Asian |
2.916100E-02 |
| AfricanAmerican-vs-Asian |
9.420200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.59319998807683E-09 |
| Normal-vs-Female |
1.449380E-01 |
| Male-vs-Female |
1.791960E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.127800E-02 |
| Normal-vs-Extreme_Weight |
1.00880004350046E-09 |
| Normal-vs-Obese |
8.628100E-04 |
| Normal-vs-Extreme_Obese |
1.562610E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.690200E-02 |
| Normal_Weight-vs-Obese |
4.503200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.979400E-01 |
| Extreme_Weight-vs-Obese |
1.077610E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.353400E-01 |
| Obese-vs-Extreme_Obese |
5.403400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.535000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.89889999957904E-07 |
| Normal-vs-Age(61-80Yrs) |
1.73839999950687E-07 |
| Normal-vs-Age(81-100Yrs) |
3.503900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.005640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.987600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.591600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.255800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.139000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.503400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.62719845878223E-11 |
| Normal-VS-Type2 PRCC |
7.63120000000228E-05 |
| Normal-VS-KIRP CIMP |
1.628410E-01 |
| Normal-VS-Unclassified PRCC |
4.373400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.584100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.061660E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.155600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.318100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.176000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.148100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.32719999999631E-05 |
| Normal-vs-N1 |
5.887600E-01 |
| Normal-vs-N2 |
5.084000E-01 |
| N0-vs-N1 |
1.963480E-03 |
| N0-vs-N2 |
4.900600E-01 |
| N1-vs-N2 |
4.590000E-01 |
|
|
